Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study

Recent studies have implicated B cells in atherosclerosis and have verified the atheroprotective effect of rituximab. Rituximab is widely used for desensitization in ABO-incompatible or crossmatch-positive kidney transplantation (KT). Using a single-center KT database, we performed propensity-matche...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Deok Gie, Lee, Juhan, Seo, Won Jun, Lee, Jae Geun, Kim, Beom Seok, Kim, Myoung Soo, Kim, Soon Il, Kim, Yu Seun, Huh, Kyu Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848081/
https://www.ncbi.nlm.nih.gov/pubmed/31712593
http://dx.doi.org/10.1038/s41598-019-52942-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848081/
https://www.ncbi.nlm.nih.gov/pubmed/31712593
http://dx.doi.org/10.1038/s41598-019-52942-8

Ejemplares similares